M. Pajares

发表

Transforming growth factor-beta1 mediates cellular response to DNA damage in situ.

Mary Helen Barcellos-Hoff, Carlos Arteaga, M. Barcellos-Hoff, 2002, Cancer research.

Advances in Brief Transforming Growth Factor-1 Mediates Cellular Response to DNA Damage in Situ 1

M. Barcellos-Hoff, R. Warters, K. Ewan, 2002 .

Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer

Á. Rubio, M. Pajares, D. Blanco, 2010, BMC Genomics.

Strategies to design clinical studies to identify predictive biomarkers in cancer research.

Pilar Nicolás, T. Choueiri, J. Tabernero, 2017, Cancer treatment reviews.

Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.

Á. Rubio, M. Pajares, L. Montuenga, 2014, Cancer research.

TGFBI expression is associated with a better response to chemotherapy in NSCLC

Ana Rouzaut, Jackeline Agorreta, M. Pajares, 2010, Molecular Cancer.

TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.

M. Pajares, M. Redrado, A. Calvo, 2016, Cancer letters.

Telomere shortening and accelerated aging in COPD: findings from the BODE cohort

B. Celli, M. Pajares, J. de-Torres, 2017, Respiratory Research.

Erratum to: Telomere shortening and accelerated aging in COPD: findings from the BODE cohort

B. Celli, M. Pajares, J. de-Torres, 2017, Respiratory Research.

Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer.

J. Alcaraz, R. Rami-Porta, J. Ramírez, 2019, Lung cancer.

New syngeneic inflammatory‐related lung cancer metastatic model harboring double KRAS/WWOX alterations

F. Lecanda, M. Pajares, M. Redrado, 2014, International journal of cancer.

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

J. Martinez-Climent, I. Wistuba, C. Behrens, 2015, BMC Genomics.

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16‐mediated Effects

S. Vicent, F. Lecanda, M. Pajares, 2018, American journal of respiratory and critical care medicine.

Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates.

C. Henschke, D. Yankelevitz, M. Vazquez, 2008, Histology and histopathology.

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients

I. Wistuba, C. Behrens, M. Pajares, 2019, Journal of clinical medicine.

Molecular Profiling of Computed Tomography Screen-Detected Lung Nodules Shows Multiple Malignant Features

Gorka Bastarrika, Jackeline Agorreta, Luis M. Montuenga, 2006, Cancer Epidemiology Biomarkers & Prevention.

Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.

Á. Rubio, M. Pajares, L. Montuenga, 2014, Cancer research.

Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress.

Y. Shiloh, M. Barcellos-Hoff, S. Ravani, 2006, Cancer research.

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

J. Martinez-Climent, I. Wistuba, C. Behrens, 2015, BMC Genomics.

A Combination of Apple Vinegar Drink with Bacillus coagulans Ameliorates High Fat Diet-Induced Body Weight Gain, Insulin Resistance and Hepatic Steatosis

R. Urtasun, J. Díaz-Gómez, M. Pajares, 2020, Nutrients.

Anaphylatoxin C5a Creates a Favorable Microenvironment for Lung Cancer Progression

John D Lambris, J. Lambris, M. Pajares, 2012, The Journal of Immunology.

Identification of Novel Deregulated RNA Metabolism-Related Genes in Non-Small Cell Lung Cancer

M. Pajares, V. Segura, D. Blanco, 2012, PloS one.

Progression for Lung Cancer Anaphylatoxin C5a Creates a Favorable

John D Lambris, J. Lambris, M. Pajares, 2012 .

This information is current as Progression Microenvironment for Lung Cancer Anaphylatoxin C 5 a Creates a Favorable

John D Lambris, J. Lambris, M. Pajares, 2012 .

Expression of Complement Factor H by Lung Cancer Cells

Luis M. Montuenga, Frank Cuttitta, Ruben Pio, 2004, Cancer Research.

Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside

E. Bandrés, M. Pajares, J. Sandoval, 2021, International journal of molecular sciences.

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.

Jackeline Agorreta, Luis M. Montuenga, Teresa Lozano, 2017, Cancer discovery.

Analysis of copy number alterations reveals the lncRNA ALAL-1 as a regulator of lung cancer immune evasion

Maite Huarte, C. Kanduri, Ivan Raimondi, 2020, The Journal of cell biology.

Phosphoinositide 3-kinase p85beta regulates invadopodium formation

M. Pajares, M. Idoate, A. Carrera, 2014, Biology Open.

The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer

I. Wistuba, C. Behrens, M. Pajares, 2018, Laboratory Investigation.

A novel protein‐based prognostic signature improves risk stratification to guide clinical management in early‐stage lung adenocarcinoma patients

I. Wistuba, C. Behrens, M. Pajares, 2018, The Journal of pathology.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

J. Yokota, D. Pisano, E. Felip, 2017, Clinical cancer research : an official journal of the American Association for Cancer Research.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition

J. Yokota, D. Pisano, E. Felip, 2017, Clinical Cancer Research.

The Oncoprotein SF2/ASF Promotes Non–Small Cell Lung Cancer Survival by Enhancing Survivin Expression

M. Pajares, L. Montuenga, R. Pio, 2010, Clinical Cancer Research.

Alternative splicing: an emerging topic in molecular and clinical oncology.

M. Pajares, A. Calvo, R. Catena, 2007, The Lancet. Oncology.

A large‐scale analysis of alternative splicing reveals a key role of QKI in lung cancer

Á. Rubio, M. Pajares, L. Montuenga, 2016, Molecular oncology.

Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinoma

J. Flores, M. Pajares, L. Montuenga, 2016, Oncotarget.

A prognostic DNA methylation signature for stage I non-small-cell lung cancer.

M. Esteller, D. Beer, Guoan Chen, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco‐induced lung cancer

J. Benítez, A. González-Neira, G. Pita, 2018, Cancer medicine.

Inhibition of TGFbeta1 Signaling Attenutates ATM Activity inResponse to Genotoxic Stress

Y. Shiloh, M. Barcellos-Hoff, S. Ravani, 2006 .

Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis

F. Lecanda, M. Pajares, D. Luis-Ravelo, 2012, Clinical Cancer Research.

Human Cancer Biology InhibitionofCollagenReceptorDiscoidinDomainReceptor-1 ( DDR 1 ) Reduces Cell Survival , Homing , and Colonization in Lung Cancer Bone Metastasis

F. Lecanda, M. Pajares, D. Luis-Ravelo, 2012 .

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

I. Wistuba, E. Felip, C. Behrens, 2018, Thorax.

Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma

A. González-Neira, G. Pita, I. Melero, 2021, Translational lung cancer research.

Identification through genome-wide association study (GWAS) of single nucleotide polymorphisms (SNPs) associated with extreme phenotypes of tobacco-induced non-small cell lung cancer (NSCLC) risk.

J. Benítez, A. González-Neira, G. Pita, 2014 .

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.

P. Massion, M. Pajares, J. de-Torres, 2013, Journal of the National Cancer Institute.

Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value

M. Rodriguez-Ruiz, A. Patiño-García, M. Pajares, 2016, Tumor Biology.

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients

I. Wistuba, C. Behrens, M. Pajares, 2014, British Journal of Cancer.

Improving selection criteria for lung cancer screening. The potential role of emphysema.

J. Weissfeld, M. Pajares, J. de-Torres, 2015, American journal of respiratory and critical care medicine.

Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).

M. Pajares, J. de-Torres, G. Bastarrika, 2015, Archivos de bronconeumologia.

Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.

I. Wistuba, E. Brambilla, C. Behrens, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients

M. Larrayoz, K. Gall-Trošelj, M. Pajares, 2015, PloS one.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1

R. López-López, M. Pajares, D. Hervás, 2019, Scientific Reports.

Methods for analysis of specific DNA methylation status.

R. Urtasun, M. Pajares, J. Sandoval, 2020, Methods.

Smokers with CT Detected Emphysema and No Airway Obstruction Have Decreased Plasma Levels of EGF, IL-15, IL-8 and IL-1ra

M. Pajares, J. de-Torres, G. Bastarrika, 2013, PloS one.

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology

M. Pajares, A. Calvo, P. Nguewa, 2011, British Journal of Cancer.

Telomere length, COPD and emphysema as risk factors for lung cancer

B. Celli, M. Pajares, J. de-Torres, 2017, European Respiratory Journal.

Expression of αCP‐4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells

Nuria Vergara-Irigaray, M. Pajares, L. Montuenga, 2007 .

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype

M. Larrayoz, M. Pajares, L. Montuenga, 2014, EMBO molecular medicine.

Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation

R. Urtasun, F. Milagro, M. Pajares, 2022, Nutrients.

Complement Factor H Is Elevated in Bronchoalveolar Lavage Fluid and Sputum from Patients with Lung Cancer

C. Witt, M. Pajares, L. Montuenga, 2010, Cancer Epidemiology, Biomarkers & Prevention.

plement Factor H Is Elevated in Bronchoalveolar Lavage B & P d and Sputum from Patients with Lung Cancer

C. Witt, M. Pajares, L. Montuenga, 2010 .

RHOB influences lung adenocarcinoma metastasis and resistance in a host‐sensitive manner

I. Wistuba, S. Vicent, F. Lecanda, 2014, Molecular oncology.

Antidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice

M. Pajares, Miriam Araña, M. Oneca, 2022, Nutrients.

Clinical Cancer esearch an Cancer Biology Oncoprotein SF 2 / ASF Promotes Non – Small Cell Lung R cer Survival by Enhancing Survivin Expression

M. Pajares, L. Montuenga, R. Pio, 2010 .

A blood–tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds

J. Prieto, C. Qian, M. Pajares, 2000, Gene Therapy.

Phosphorylated tubulin adaptor protein CRMP‐2 as prognostic marker and candidate therapeutic target for NSCLC

S. Llanos, M. Pajares, L. Montuenga, 2013, International journal of cancer.

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.

M. Pajares, C. Camps, L. Montuenga, 2015, Oral diseases.

YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.

I. Wistuba, E. Felip, C. Behrens, 2019, American journal of respiratory and critical care medicine.

EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration

Y. Martinet, P. Hainaut, E. Brambilla, 2009, European Respiratory Journal.

A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer

Antoni Rosell, Juan Sandoval, Luis M. Montuenga, 2016, Clinical Cancer Research.

Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.

I. Wistuba, F. Lecanda, M. Pajares, 2012, American journal of respiratory and critical care medicine.

Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators.

E. Rakha, J. Lanchbury, M. Pajares, 2015, European journal of cancer.

Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance

I. Wistuba, C. Behrens, J. García-Foncillas, 2011, Clinical Cancer Research.

Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients

M. Esteller, M. Pajares, J. Sandoval, 2016, Oncotarget.

Identification of Importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens

M. Pajares, A. Calvo, P. Nguewa, 2008, BMC Molecular Biology.

Pediococcus acidilactici pA1c® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota

R. Urtasun, F. Milagro, M. Pajares, 2023, Pharmaceutics.

Elevated Levels of the Complement Activation Product C4d in Bronchial Fluids for the Diagnosis of Lung Cancer

C. Razquín, L. Paz-Ares, M. Pajares, 2015, PloS one.

TRAP1 Regulates Proliferation, Mitochondrial Function, and Has Prognostic Significance in NSCLC

A. Harris, D. Ferguson, F. Iborra, 2014, Molecular Cancer Research.

Cell Cycle and Senescence TRAP 1 Regulates Proliferation , Mitochondrial Function , and Has Prognostic Signi fi cance in NSCLC

A. Harris, D. Ferguson, F. Iborra, 2014 .

Complement C4d-specific antibodies for the diagnosis of lung cancer

P. Massion, U. Pastorino, A. Blom, 2017, Oncotarget.

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1.

R. López-López, M. Pajares, D. Hervás, 2019 .

Abstract LB-084: Dasatinib reduces tumor growth in xenograft models derived from human lung tumors with YES1 overexpression

L. Paz-Ares, M. Pajares, L. Montuenga, 2018, Experimental and Molecular Therapeutics.

Abstract LB-117: Dasatinib for the treatment of patients with non-small cell lung cancer harboring YES1 amplification

I. Wistuba, C. Behrens, M. Pajares, 2017 .

MA17.10 YES1 Kinase is a New Therapeutic Target in Non-small Cell Lung Cancer